Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
LONDON - Primary Health Properties PLC (PHP), a leading investor in modern primary healthcare facilities in the UK, has announced the publication of its Annual Report for the year ended December 31, 2024. The report is now accessible on the company’s website. In conjunction with the release of the annual report, PHP has also issued notice of its forthcoming Annual General Meeting (AGM), scheduled to take place on May 7, 2025, at 10:30 a.m. UK time.
The AGM will be held at the offices of CMS Cameron McKenna Nabarro Olswang LLP, located at Cannon Place, 78 Cannon Street, in London. Shareholders are invited to attend and vote, with the option to participate in person, remotely, or by proxy. The company has specified that only shareholders listed in the register of members as of 6:30 p.m. UK time on May 2, 2025, will be eligible to attend and vote at the AGM. Any changes to the register after this time will not be considered for determining voting rights at the meeting or any adjourned sessions.
In preparation for the AGM, PHP has also made available a form of proxy for shareholders to use at the meeting. Both the AGM Notice and the proxy form can be found on PHP’s website. Printed copies of these documents, along with the Annual Report 2024, have been dispatched to shareholders as of today.
The company has fulfilled its regulatory obligations by submitting copies of the Annual Report 2024, the AGM Notice, and the proxy form to the National Storage Mechanism, where they will soon be available for public inspection.
The announcement of the AGM and the publication of the annual report are routine corporate governance practices, allowing shareholders to review the company’s performance and make informed decisions on the resolutions to be presented at the AGM. This information is based on a press release statement issued by Primary Health Properties PLC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.